ISSN: 2329-9509
+44 1478 350008
Department of Oral Pathology, School of Dentistry, Federal University of Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos, 2492/503, ZIPCODE 90035-003, Porto Alegre RS, Brazil
Commentary
Efficacy and Security of Anti-Sclerostin Antibodies within the Treatment of Osteoporosis
Author(s): Adriana Oliveira*
Osteoporosis could be an inveterate infection with an expanding predominance. Anti-sclerostin antibodies are
being explored for the treatment of osteoporosis. This point of this precise audit and meta-analysis is to assess the
viability and security of antis-sclerostin antibodies compared to fake treatment and ordinary treatments (alendronate
and teriparatide) within the treatment of osteoporosis. Randomized controlled trials were looked from PubMed,
EMBASE and Cochrane Central Enroll of Controlled Trails (CENTRAL) from their initiation up to June 2021
by utilizing Restorative Subject Headings terms ?anti-sclerostin antibody?, ?romosozumab?, ?blosozumab?, ?AMG
785?, ?LY2541546?, and ?osteoporosis?. Two examiners freely screened qualified thinks about, evaluated the
hazard of predisposition and extricated the information from each think about. The I2 file was utilized to survey
he.. View More»
DOI:
10.35841/2329-9509.22.10.328